However, using PSMA PET/CT as a supportive imaging diagnostic technique for response evaluation, there was a significant correlation between PSA changes and the treatment response according to images, which increases the value of PSA as a reliable tumor marker for the follow-up of these patients [49]. This evidence concerns the gene FOLH1 and neoplasm.